XCL1
1,333.00 ¥ 1,333.00 ¥ 1333.0 CNY
XCL1
1,333.00 ¥ 1,333.00 ¥ 1333.0 CNY
XCL2
1,333.00 ¥ 1,333.00 ¥ 1333.0 CNY
Brentuximab vedotin (anti-CD30)
319.00 ¥ 319.00 ¥ 319.0 CNY
Iscalimab (anti-CD40)
2,667.00 ¥ 2,667.00 ¥ 2667.0 CNY
Dostarlimab (anti-PD-1)
2,667.00 ¥ 2,667.00 ¥ 2667.0 CNY
Lintuzumab (anti-CD33)
229.00 ¥ 229.00 ¥ 229.0 CNY
Lorvotuzumab mertansine (anti-NCAM1)
509.00 ¥ 509.00 ¥ 509.0 CNY
Pidilizumab (anti-PD-1)
229.00 ¥ 229.00 ¥ 229.0 CNY
Retifanlimab (anti-PD-1)
2,667.00 ¥ 2,667.00 ¥ 2667.0 CNY
Rovelizumab (anti-CD11a&CD18)
139.00 ¥ 139.00 ¥ 139.0 CNY
Sugemalimab (anti-PD-L1)
2,667.00 ¥ 2,667.00 ¥ 2667.0 CNY
Tisotumab vedotin (anti-Tissue Factor)
2,667.00 ¥ 2,667.00 ¥ 2667.0 CNY
Trastuzumab emtansine (anti-ERBB2)
2,667.00 ¥ 2,667.00 ¥ 2667.0 CNY
Zimberelimab (anti-PD-1)
2,667.00 ¥ 2,667.00 ¥ 2667.0 CNY
Vofatamab (anti-FGFR3)
1,219.00 ¥ 1,219.00 ¥ 1219.0 CNY
CSL311 (anti-CSF2Rb)
1,109.00 ¥ 1,109.00 ¥ 1109.0 CNY
FR104 (anti-CD28)
1,109.00 ¥ 1,109.00 ¥ 1109.0 CNY
Coltuximab (anti-CD19)
1,109.00 ¥ 1,109.00 ¥ 1109.0 CNY
Divozilimab (anti-CD20)
959.00 ¥ 959.00 ¥ 959.0 CNY